InvestorsHub Logo
Followers 486
Posts 74627
Boards Moderated 2
Alias Born 10/26/2000

Re: cjstocksup post# 113136

Friday, 05/01/2015 9:24:50 AM

Friday, May 01, 2015 9:24:50 AM

Post# of 130513
Dr. Rubinfeld was one of four co-founders of Amgen, Inc. and served as its Chief of Operations, where one of his primary efforts was the prioritization of erythropoietin (EPO) in Amgen’s pipeline due to its initial commercialization pathway under the Orphan Drug Act.

that is key